For those working toward preventive care goals, preserving strength aligns with long-term metabolic health
There are clear situations where it makes more sense than tirzepatide, and dismissing it entirely because tirzepatide produces more weight loss would be a mistake
As of April 2026, Wegovy is available in all doses, and the FDA has declared its previous shortage as resolved
IV glutathione compares to oral supplements with higher bioavailability but poorer clinical outcomes and safety
Start your intake Understanding the FDA-Approved Dosing Pathway The FDA-approved dosing schedule for semaglutide (Wegovy) follows a 16-week titration protocol: weeks 1-4 at 0.25 mg, weeks 5-8 at 0.5 mg, weeks 9-12 at 1 mg, weeks 13-16 at 1.7 mg, then maintenance at 2.4 mg
Tirzepatide not only mimics GLP-1, but also mimics GIP, a hormone that enhances the release of insulin following food intake